CDC-RFA-PS20-2008.pdf

Centers for Disease Control and Prevention

National Center for HIV-AIDS, Viral Hepatitis, STD, and TB Prevention

Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS)

CDC-RFA-PS20-2008

Application Due Date: 05/11/2020

Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS)

CDC-RFA-PS20-2008

TABLE OF CONTENTS

Part I. Overview Information A. Federal Agency Name B. Funding Opportunity Title C. Announcement Type D. Agency Funding Opportunity Number E. Assistance Listings (CFDA) Number F. Dates G. Executive Summary

Part II. Full Text A. Funding Opportunity Description B. Award Information C. Eligibility Information D. Application and Submission Information E. Review and Selection Process F. Award Administration Information G. Agency Contacts H. Other Information I. Glossary

Part I. Overview Information Applicants must go to the synopsis page of this announcement at www.grants.gov and click on the "Subscribe" button link to ensure they receive notifications of any changes to CDC-RFA- PS20-2008. Applicants also must provide an e-mail address to www.grants.gov to receive notifications of changes.

A. Federal Agency Name:

Centers for Disease Control and Prevention (CDC) / Agency for Toxic Substances and Disease Registry (ATSDR) B. Notice of Funding Opportunity (NOFO) Title:

Community-Based Approaches to Reducing Sexually Transmitted Diseases (CARS) C. Announcement Type: New - Type 1 This announcement is only for non-research activities supported by CDC. If research is proposed, the application will not be considered. For this purpose, research is defined at https ://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf.

Guidance on how CDC interprets the definition of research in the context of public health can be found at https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html (See section 45 CFR 46.102(d)).

D. Agency Notice of Funding Opportunity Number:

CDC-RFA-PS20-2008

E. Assistance Listings (CFDA) Number:

93.978 F. Dates:

1. Due Date for Letter of Intent (LOI): 04/13/2020

2. Due Date for Applications: 05/11/2020, 11:59 p.m. U.S. Eastern

Standard Time, at www.grants.gov.

3. Date for Informational Conference Call:

Informational conference call for potential applicants Monday, March 23, 2020 1:00-2:30pm

EST

Join Skype Meeting Trouble Joining? Try Skype Web App Join by phone

(404) 553-8912 (Atlanta Dial-in Conference Region) English (United States)

(855) 348-8390 (Atlanta Dial-in Conference Region) English (United States) Find a local number Conference ID: 9285150

G. Executive Summary:

1. Summary Paragraph:

https://www.grants.gov https://www.grants.gov https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.gpo.gov/fdsys/pkg/CFR-2007-title42-vol1/pdf/CFR-2007-title42-vol1-sec52-2.pdf https://www.hhs.gov/ohrp/regulations-and-policy/regulations/45-cfr-46/index.html https://www.grants.gov https://webconf.cdc.gov/nhh9/4M92RZHC https://webconf.cdc.gov/nhh9/4M92RZHC?sl=1 tel:(404)%20553-8912 tel:(855)%20348-8390 https://webaudio.cdc.gov/

The Centers for Disease Control and Prevention (CDC) announces the availability of Fiscal Year (FY) 2020 funds for a cooperative agreement supporting organizations with demonstrated experience and capacity of implementing community engagement methods and multi-sector partnerships, to reduce STD disparities, promote personal health, advance community wellness, and improve personal health behavior and practices. The new notice of funding opportunity (NOFO) provides support in five focus areas. The first two focus areas are implementation of community engagement methods to achieve health equity; and implementation of structural change strategies that promote personal health, support healthy behaviors, and community-clinical linkages to build support for interventions to prevent and reduce STD disparities. The other three focus areas are enhancement and sustainability of partnerships; support for communication strategies to promote STD program successes and leverage additional resources for STD control and prevention; and evaluation of the efficacy of this approach and intervention implementation.

a. Eligible Applicants: Open Competition

b. NOFO Type: Cooperative Agreement

c. Approximate Number of Awards: 4

d. Total Period of Performance Funding: $3,750,000

e. Average One Year Award Amount: $312,500

f. Total Period of Performance Length: 3

g. Estimated Award Date: 08/30/2020

h. Cost Sharing and / or Matching Requirements: N

Part II. Full Text A. Funding Opportunity Description

Part II. Full Text

1. Background

a. Overview Sexually Transmitted Diseases (STDs) remain one of the most critical public health challenges facing the United States (U.S.), with approximately 20 million new STD infections occurring every year. Half of these new infections occur in young people ages 15-24. These infections can lead to long-term health consequences, such as infertility; they can facilitate HIV transmission;

and they have stigmatized entire subgroups of Americans. Beyond the impact on an individual's health, STDs are also an economic drain on the U.S. healthcare system, costing billions annually.

In 2018 1,758,688 cases of Chlamydia trachomatis infection were reported to the CDC, making it the most common notifiable condition in the U.S. This case count corresponds to a rate of

539.9 cases per 100,000 population, an increase of 2.9% compared with the rate in 2017. During

2017-2018, rates of reported chlamydia increased among both males and females in all regions of the U.S., and among all racial and Hispanic ethnicity groups.

In 2018, almost two-thirds of all reported chlamydia cases were among persons aged 15-24 years. Among females aged 15-24 years, the population targeted for chlamydia screening, the overall rate of reported cases of chlamydia was 3,693.6 cases per 100,000 females; an increase of 1.0% from 2017 and of 11.8 from 2014.

In 2018, 583,405 cases of gonorrhea were reported in the U.S. Rates of reported gonorrhea have increased 82.6% since the historic low in 2009. During 2017-2018, the overall rate of reported gonorrhea increased 5.0%, and rates increased among both males and females, in all regions of the U.S., and among all racial/Hispanic ethnicity groups. The South had the highest rate of reported gonorrhea cases (194.4 cases per 100,000 population) among the four regions of the U.S. in 2016, followed by the Midwest (184.5 cases per 100,000 population). The rate of reported gonorrhea cases remained highest among Blacks (548.9 cases per 100,000 population).

The rate among Blacks was 7.7 times the rate among Whites (71.1 cases per 100,000 population).

In 2018, 115,045 cases of all stages of syphilis, were reported; including 35,063 cases of primary and secondary (P&S) syphilis--the most infectious stages of the disease. Since reaching a historic low in 2000 and 2001, the rate of P&S syphilis has increased almost every year, increasing 14.9% during 2017-2018. Rates increased among both males and females, in all regions of the U.S., and among all racial/Hispanic ethnicity groups. Since 2000, rates of P&S syphilis have increased among men, primarily attributable to increases in cases among MSM.

Similar to past years, in 2018, MSM accounted for the majority (53.5%) of all reported cases of P&S syphilis and, of these, 41.6% were known to be living with diagnosed HIV.

The 2018 CDC STD surveillance data show there are higher rates of reported STDs among some minority populations when compared to rates among Whites. Health disparities in HIV, viral hepatitis, STDs, and TB are inextricably linked to a complex blend of social determinants that influence which populations are most severely affected by these diseases. Collaborating with these disproportionately affected communities in the design, delivery, and evaluation of public health interventions is essential for an effective response addressing the reduction of STD rates.

Centers for Disease Control and Prevention (CDC), Sexually Transmitted Diseases Surveillance 2018 https://www.cdc.gov/std/stats15/default.htm

b. Statutory Authorities This program is authorized under Section 301(a) of the Public Health Service Act (42 U.S.C. Section 241(a)) and 318 (a)(b)(c) of the Public Health Service Act [42 U.S.C. Section 247c (a)(b) and (c)] as amended. Regulations governing the implementation of this legislation are covered under 42 CFR Part 51b, Subpart A.

c. Healthy People 2030 Due to the substantial STD burden, the U.S. Department of Health and Human Services has identified 10 specific Healthy People objectives for 2020 (http://www.healthypeople.gov/2020 /topicsobjectives2020/objectiveslist.aspx?topicId=37). Some of the objectives include:

https://www.cdc.gov/std/stats15/default.htm http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=37 http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=37

Reduce the proportion of adolescents and young adults with Chlamydia trachomatis infections.

Reduce Chlamydia rates among females aged 15-44 years.

Reduce gonorrhea rates.

Reduce sustained domestic transmission of primary and secondary syphilis, congenital syphilis.

Reduce the proportion of young adults with genital herpes infection due to herpes simplex type 2.

d. Other National Public Health Priorities and Strategies Promoting Health Equity The program supports efforts to improve the health of populations disproportionately affected by HIV/AIDS, viral hepatitis, STDs and TB by maximizing the health impact of public health services, reducing disease prevalence, and promoting health equity, aligning with CDC's National Center for HIV, Viral Hepatitis, STD, and TB Prevention's (NCHHSTP) Strategic Plan Through 2020 (https://www.cdc.gov/nchhstp/strategicpriorities/).

e. Relevant Work This NOFO builds upon previous and current STD prevention programs including:

CDC-RFA-PS11-1114: http://www.grants.gov/web/grants/view-opportunity.html?oppId=72774 CDC-RFA-PS14-1406: http://www.grants.gov/web/grants/view-opportunity.html?oppId=25120 CDC-RFA-PS17-1707: https://www.grants.gov/web/grants/view-opportunity.html?oppId =290103 First established in 2011, the Community Approaches to Reducing Sexually Transmitted Diseases (CARS) cooperative agreement supported planning, implementation, and evaluation of innovative projects to reduce STD disparities, promote personal health, and advance community wellness using community engagement methods. In three separate funding cycles of 2011-2014, 2014-2017, and 2017-2020, four new recipients received funding in each cycle to implement projects and activities.

2. CDC Project Description

a. Approach

Bold indicates period of performance outcome.

Logic Model: Community-Based Approaches to Reducing STD Disparities

Strategies Short Term Outcomes

Intermediate Outcomes

Long Term Outcomes https://www.cdc.gov/nchhstp/strategicpriorities/ http://www.grants.gov/web/grants/view-opportunity.html?oppId=72774 http://www.grants.gov/web/grants/view-opportunity.html?oppId=251204 http://www.grants.gov/web/grants/view-opportunity.html?oppId=251204 https://www.grants.gov/web/grants/view-opportunity.html?oppId=290103 https://www.grants.gov/web/grants/view-opportunity.html?oppId=290103

(Year 1) (Year 2-3) (Year 4- beyond)

Community Engagement -Establish a Community Advisory Board (CAB) reflecting at-risk groups Identification and Implementation of system environmental strategies

- Conduct Community Needs Assessment

- Train CAB and engage CAB in Social Determinants of Health (SDOH) impact/prioriti zation based on Needs Assessment

- Coordinate CAB design of STD intervention to address SDOH needs

Develop multi-sectorial partnerships

- Engage partners for intervention implementation

- Leverage resources for intervention implementation

- Establish detailed MOUs Communication

- Develop and implement effective communication strategies

Increased CAB members who actively participate in and are satisfied with the CAB Increased prioritization of community social determinants of health by the CAB Increased clinical resources identified to address needs Increased effective CAB-designed STD interventions for target groups Increased new stable partnerships to address community needs Increased awareness of STD disparities among target groups most impacted Increased awareness of personal health issues affecting target groups and community resources that address needs

Increased linkages with and access to target groups

Increased existing clinical resources for target groups identified by the

CAB

Increased number and sustainability of CAB-designed STD interventions using partner resources and influence Increased access to/use of community health and resources, STD screening and support services by target groups most impacted by STD disparities Increased access to/use of educational and economic opportunitie s identified in needs assessment by target groups most impacted by STD disparities

Decreased risky sexual behavior among target groups most impacted

Decreased STD disparities among target groups most impacted

Increased quality STD prevention services (e.g., health care providers, services more readily accessible)

Decreased effect of social issues related to STD transmission

Evaluation/CQI

- Evaluate community engagement, partnerships, and interventions

i. Purpose This program is to implement community engagement methods to achieve health equity, via the identification and implementation of structural strategies promoting personal health. Recipients will support healthy behaviors, facilitate community-clinical linkages to build support for interventions to prevent and reduce STD disparities, enhance and sustain partnerships, support communication strategies that promote STD program successes and leverage additional resources for STD, HIV, viral hepatitis control and prevention, and evaluate the efficacy of this intervention approach.

ii. Outcomes Recipients will demonstrate measurable progress in:

Short-term Community Engagement:

Increased CAB members who actively participate in and are satisfied with the CAB

Identification and Implementation of system environmental strategies:

Increased prioritization of community social determinants of health by the CAB;

Increased clinical resources identified to address community needs;

Increased effective CAB-designed STD interventions for target groups;

Increased awareness of STD disparities (e.g., high rates of reported chlamydia, gonorrhea cases among African Americans and Latinos) among target groups most impacted (e.g., adolescents, YMSM, and MSM); and

Increased awareness of personal health issues (e.g., lack of STD prevention and treatment services) affecting target groups, and community resources that address these needs.

Multi-sectorial Partnerships:

Increased new stable partnerships to address community needs

Intermediate

Increased linkages with and access to target groups Increased existing clinical resources for target groups identified by the CAB Increased number and sustainability of CAB-designed STD interventions using partner resources and influence

iii. Strategies and Activities Recipients will conduct the activities described below in each of the following Program Strategy areas.

Community Engagement:

Conduct effective community engagement activities (e.g. existing community advisory boards, coalitions, advocates, etc.);

Within the first 3 months, engage the Community Advisory Board (CAB) where at least 85% of members reflect the targeted community most impacted by STD disparities and report using the CAB representation table using the template that CDC will provide within the first 30 days of award (CAB members must be community members from the target population, NOT organizations that represent or work with the target population);

Ensure the CAB infrastructure is equitable for ALL members and suitable for conducting the business of the board in an efficient manner; and

Utilize evaluation, meeting facilitation and continuous quality improvement techniques to ensure active CAB meeting participation, member satisfaction and commitment, sense of ownership and decision-making power.

Identification and implementation of structural strategies:

Within the first 6 months, document and analyze via a community needs assessment, the extent of disparities and the effects of social determinants of health (SDOH) on the local community;

Within the first 12 months, engage the CAB in the identification of community priorities for SDOH and STD, HIV, and viral hepatitis prevention strategies;

Within the first 12 months, use the CAB feedback and community needs assessment data to design a program plan to reduce disparities that addresses SDOH;

Within the first 12 months, ensure the incorporation of public health ethics in the program plan;

Outline specific strategies planned to ensure public health ethics compliance;

Implement CAB designed interventions using partner resources and influence; and Conduct community outreach events and programs for the target group most impacted by STD disparities.

Multi-sectorial Partnerships:

Partner with other health, non-health, and social service providers (e.g. community health centers, faith-based organizations, mental health agencies, middle and secondary schools, community college networks, professional associations, local health departments, correctional facilities, local businesses) to provide STD, HIV, and viral hepatitis prevention information and referrals, behavioral risk counseling, individual-level interventions and community-designed interventions as identified in the program plan. Within the first 12 months, execute Memorandum of Understanding (MOU) for at least 75% of partners. MOUs must detail specific contributions and supporting activities for partnering programs and/or organizations.

Communication:

Develop and implement effective communication strategies to increase awareness of STD disparities, health issues and community resources among the target population most impacted by STD disparities; and

Utilize communication strategies to promote STD program success and leverage additional resources for STD, HIV, and viral hepatitis prevention.

Evaluation:

Within the first 3 months, develop a logic model describing program inputs, activities, service outputs, immediate outcomes and long-term outcomes;

Within the first 6 months, develop SMART objectives that relate to the overall goal of the project. At least one objective must outline how the recipient plans to expand or build upon the existing community advisory board; and

Within the first 6 months, develop an evaluation plan matrix with evaluation questions, indicators related to the SMART objectives, proposed data collection methods, and timeline. Initial plan should include intentions for the three-year funding period.

1. Collaborations

a. With other CDC programs and CDC-funded organizations:

CARS recipients will also collaborate with Ending the HIV Epidemic (EHE) and other domestic HIV-funded programs to achieve shared health outcome objectives as appropriate.

b. With organizations not funded by CDC:

Recipients are expected to build and/or continue strategic partnerships and collaborations with other health, non-health sector, and social service providers (e.g., community health centers, faith-based organizations, mental health agencies, schools, community college networks, professional associations, local health departments, correctional facilities), and others that have a role in achieving the outcomes and proposed activities of this NOFO.

2. Target Populations Applicants should use epidemiologic and social determinants data, e.g., surveillance data from state and local health departments, to identify communities disproportionately affected by STDs including HIV and viral hepatitis within their jurisdictions, and should ensure that program activities appropriately cover these populations.

Populations of interest to this funding opportunity include:

Young men-who-have-sex-with-men (YMSM);

Men-who-have-sex-with-men (MSM) and other vulnerable populations seen in HIV care and other selected facilities;

Young transgender persons of color (YTG of color); and Adolescents and young adults diagnosed with an STD of interest.

a. Health Disparities This NOFO is inclusive of all vulnerable populations including people with disabilities, non- English speaking populations, LGBTQ populations, and people with limited health literacy, and racial/ethnic minorities.

All applicants must design their program so that it is accessible and available to YMSM of color and YTG persons of color. Disparities by race, ethnicity, gender identity, sexual orientation, geography, socioeconomic status, disability status, primary language, health literacy, and other relevant dimensions (e.g., tribal communities) should be considered when developing the proposed program and identifying the target population(s). Organizations funded under this NOFO will be required to provide services to the primary target population(s) specified in their applications. Organizations funded under this NOFO are required to provide services, regardless of their race, ethnicity, or other demographic characteristics. In addition, the target population described in the work plan and narrative must match the target population identified in the Proposed Target Population Worksheet.

iv. Funding Strategy N/A

b. Evaluation and Performance Measurement

i. CDC Evaluation and Performance Measurement Strategy The CDC evaluation team will:

Conduct a comprehensive evaluation, based on the CARS logic model. Data collection methods will include evaluation assessments, observations, document reviews and key informant interviews.

Collect data on the common evaluation measures listed under the measurable outcomes section of the executive summary. This data will be included in the annual evaluation reports.

Measures and Indicators of interest include:

Community Engagement:

Process: Number of members from priority population attending Community Advisory Board (CAB) meetings; level of satisfaction of Community Advisory Board members; number of interventions/strategies aimed to address social determinants of health impacting health equity within affected communities; number of social determinants identified by CAB; perceived power of CAB members; perceived ownership of membership structure; perceived sustainability of community engagement methods; perceived improvement in advocacy skills among CAB members.

Outcome: Increased CAB members who actively participate in and are satisfied with the CAB

Measures: Number of members from the priority population attending CAB meetings; level of satisfaction of the CAB board members Identification and implementation of system and environmental strategies:

Process: Number of existing clinical resources identified; number of trainings available; number of community-designed STD prevention strategies identified by CAB Outcome: Increased prioritization of community social determinants of health by the CAB Measure: Number of social determinants of health identified by CAB members Outcome: Increased clinical resources identified to address needs Measure: Number of existing clinical resources identified Outcome: Increased effective CAB-designed STD interventions for target groups Measure: Number of community-designed interventions/strategies that address social determinants of health impacting health equity within affected communities; Positivity and treatment rates from community-designed STD prevention interventions; Additional measures will be finalized with recipients Outcome: Increased existing clinical resources for target groups identified by the CAB Measure: Number of existing clinical resources identified by CAB members, number of STD clinical resource listings/info cards disseminated; additional measures will be finalized with the recipients Outcome: Increased linkages with and access to target groups Measure: Measures will be finalized with the recipients Outcome: Increased number and sustainability of CAB-designed STD interventions using partner resources and influence Measure: Perceived sustainability of CAB-designed interventions, number of sustainable CAB-designed interventions in place, additional measures will be finalized with recipients Partnerships:

Process: Multi-sector partner participation rate; proportion of partners engaged in community and intervention activities; value of leveraged resources; number of policies adopted or refined Outcome: Increased new stable partnerships to address community needs Measure: Number of new partnerships formed by sector; additional measures will be finalized with the recipients Communication:

Process: Effectiveness of communication efforts Outcome: Increased awareness of STD disparities among target groups most impacted Increased awareness of personal health issues affecting target groups and community resources that address needs Measure: Perceived increase awareness of STD disparities; additional measures will be finalized with the recipients Evaluation Recipients will be required to submit a detailed Evaluation and Performance Measurement plan, including a Data Management and Access Plan (DMP) within the first 6 months of award, as described in the Reporting Section of this NOFO. Data collected is for ongoing monitoring of the award to evaluate its effectiveness, and for continuous program improvement.

The Evaluation and Performance Measurement plan must:

Identify staff person responsible for conducting and reporting evaluation activities;

Describe how key program partners will be engaged in the evaluation and performance measurement planning processes;

Outline the type of evaluations conducted (i.e., process and/or outcome);

List key evaluation questions;

Identify potentially available data sources and feasibility of collecting appropriate evaluation and performance data;

Discuss how evaluation findings will support continuous program and quality improvement;

Provide one example (as an attachment) of a well-designed evaluation assessment tool used during past evaluation efforts;

Describe other information, as determined by the CDC program (e.g., performance measures developed by the applicant) that must be included;

Recipient shall report on process and outcome evaluation measures annually, and directly relate measures to the logic model (service outputs and outcomes) and outcomes listed in this announcement. Measures should be stratified by funding year and include indicators for each funding year.

Recipient will be required to submit evaluation reports, according to the CDC provided reporting schedule and templates; and

Recipient shall report and disseminate success stories related to CARS community engagement, partnerships, interventions, and/or evaluation annually.

Evaluation questions recipients are expected to address include:

Community Engagement

To what extent do CARS recipients develop CABs that reflect the target community, have a strong sense of power and make decisions about community approaches to reducing STDs and priority social determinants of health?

To what extent are evidence-based methods used for decision-making and consensus building?

To what extent are CAB members involved in the development of interventions;

prioritization of social determinants of health; planning of evaluation activities; analysis of evaluation data; dissemination of results; and manuscripts and publications?

What are the barriers and facilitators to developing an efficient CAB that reflects the target community?

Partnerships

To what extent do the recipients have the appropriate partnerships in place to help ensure successful implementation of community-designed interventions?

To what extent are partner resources leveraged to reach intended target populations and implement and sustain community-designed STI prevention interventions?

Identification and Implementation of Systems and Environmental Strategies

What types of trainings are offered in the effort to ensure successful implementation of

CARS?

What interventions are proposed and designed by the CAB?

To what extent are specific community-designed STI prevention interventions being implemented, using existing and partner resources?

What is the yield of screening and community-designed STI prevention interventions?

To what extent does this community engagement approach increase access to and awareness of services: STI and specific social services identified as a priority by the

CAB?

Communication

What communication strategies are effective in reaching the target population?

To what extent were communication efforts successful in achieving the specific call-to-action?

What communication strategies, if any, did not work well?

To what extent did the CAB contribute to the development of effective communication strategies?

ii. Applicant Evaluation and Performance Measurement Plan Applicants must provide an evaluation and performance measurement plan that demonstrates how the recipient will fulfill the requirements described in the CDC Evaluation and Performance Measurement and Project Description sections of this NOFO. At a minimum, the plan must describe:

How applicant will collect the performance measures, respond to the evaluation questions, and use evaluation findings for continuous program quality improvement.

How key program partners will participate in the evaluation and performance measurement planning processes.

Available data sources, feasibility of collecting appropriate evaluation and performance data, and other relevant data information (e.g., performance measures proposed by the applicant)

Plans for updating the Data Management Plan (DMP), if applicable, for accuracy throughout the lifecycle of the project. The DMP should provide a description of the data that will be produced using these NOFO funds; access to data; data standards ensuring released data have documentation describing methods of collection, what the data represent, and data limitations; and archival and long-term data preservation plans.

For more information about CDC’s policy on the DMP, see https://www.cdc.gov/grants/additionalrequirements/ar-25.html.

Where the applicant chooses to, or is expected to, take on specific evaluation studies, they should be directed to:

Describe the type of evaluations (i.e., process, outcome, or both).

Describe key evaluation questions to be addressed by these evaluations.

Describe other information (e.g., measures, data sources).

Recipients will be required to submit a more detailed Evaluation and Performance Measurement plan, including a DMP, if applicable, within the first 6 months of award, as described in the Reporting Section of this NOFO.

c. Organizational Capacity of Recipients to Implement the Approach Successful applicants must have the organizational capacity to carry out the strategies and activities described above. Applicants should demonstrate the following:

An existing relationship with the target population in the form of a Community Advisory Board/Council (CAB), and evidence that the CAB reflects and represents the target community. Applicants must include evidence via a table or spreadsheet, demonstrating the CAB reflects and represents (i.e. race/ethnicity, sexual orientation, gender, age, etc.) the target community. (Applicants must name the file ?CAB Representation Table? and upload as a PDF file under ?Other Attachment Forms? on www.grants.gov ).

The CAB infrastructure must be suitable for conducting business in an effective and efficient manner.

The ability to leverage partner resources and infrastructure.

A staffing plan and an organizational chart, including proposed staffing, with roles clearly stated. (Applicants must name this file "Organizational Charts" and upload it at www.grants.gov).

Background, experience, and Curricula Vitae (CV) for key staff to indicate ability to carry out the purposes of the program. (Applicants must include CV or resumes for key staff. Applicants should name the file ?Staff CVs/Resumes? and upload as a PDF file under ?Other Attachment Forms? on www.grants.gov) .

Proposed project management experience and ability to plan, organize, secure and manage resources to successfully accomplish program activities.

A plan for disseminating project findings.

Willingness and the capacity to collaborate with other recipients and adhere to common protocols.

https://www.cdc.gov/grants/additionalrequirements/ar-25.html http://www.grants.gov/ http://www.grants.gov/

In addition, applicants must have a financial management system, i.e., an accounting system. At a minimum, this system must:

permit preparation of required reports;

allow the tracking of funds;

have effective internal accountability controls/checks and balances;

maintain source documents; and have a cash management system to accurately account for cash transactions.

d. Work Plan Applicants are required to provide a work plan consisting of period of performance goals for the three-year program and Year One outcomes for each program strategy. A detailed description of program activities in each area during the first year of the award is also required. The work plan should not exceed 20 pages. Applicants are strongly encouraged to use the activities indicated under the "Program Strategy" section. The work plan must include:

Period of Performance Goals (PPG) for each Program Strategy. The proposed PPGs should describe the goals for the 3-year period of performance.

Annual Outcomes (AO) for each PPG. The proposed AOs should describe the short-term outcomes for the first year of the period of performance. Each AO must be specific, measurable, achievable, realistic time-phased (SMART) goals and consistent with the intent of the program announcement.

A description of specific program activities that are undertaken during the first year to meet the proposed Annual Outcomes. The activity descriptions must include (1) timeline for completion; (2) staff responsible for completion of activity, including the level of effort and allocation of time for each proposed activity; and (3) key partners involved in the development, implementation and evaluation of proposed activities, including a description of their role.

Note: Write annual outcomes in SMART format. Provide quantitative baselines for each outcome that leads to an increase, decrease, or maintenance over time. Activities must be in alignment with the proposed objectives and the chosen program strategies and must include those activities the applicant selects as priority, based on the cited evidence, for the first year of the project.

CDC will provide feedback and technical assistance to recipients to finalize the work plan post-award.

e. CDC Monitoring and Accountability Approach Monitoring activities include routine and ongoing communication between CDC and recipients, site visits, and recipient reporting (including work plans, performance, and financial reporting).

Consistent with applicable grants regulations and policies, CDC expects the following to be included in post-award monitoring for grants and cooperative agreements:

Tracking recipient progress in achieving the desired outcomes.

Ensuring the adequacy of recipient systems that underlie and generate data reports.

Creating an environment that fosters integrity in program performance and results.

Monitoring may also include the following activities deemed necessary to monitor the award:

Ensuring that work plans are feasible based on the budget and consistent with the intent of the award.

Ensuring that recipients are performing at a sufficient level to achieve outcomes within stated timeframes.

Working with recipients on adjusting the work plan based on achievement of outcomes, evaluation results and changing budgets.

Monitoring performance measures (both programmatic and financial) to assure satisfactory performance levels.

Monitoring and reporting activities that assist grants management staff (e.g., grants management officers and specialists, and project officers) in the identification, notification, and management of high-risk recipients.

f. CDC Program Support to Recipients (THIS SECTION APPLIES ONLY TO

COOPERATIVE AGREEMENTS)

CDC's CARS Coordination Team will host a CDC/Recipient meeting at the beginning of the period of performance to facilitate an introduction of all CDC CARS Team members, Office of Grant Services (OGS) Management Specialist, and recipients. Additional CDC Program support shall include, but is not limited to:

Providing technical program expertise and assistance;

Sharing current project-relevant published articles and research;

Providing expert evaluation guidance;

Facilitating CARS recipient collaboration through regular scheduled meetings and webinars; and Providing a platform for information and resource sharing among recipients, facilitating further exploration of innovative community engagement approaches to address social determinants of health, and ultimately reducing disparate rates of STDs in identified communities.

B. Award Information

1. Funding Instrument Type: Cooperative Agreement CDC's substantial involvement in this program appears in the CDC Program Support to Recipients Section.

2. Award Mechanism: U22

3. Fiscal Year: 2020

4. Approximate Total Fiscal Year Funding: $1,250,000

5. Approximate Period of Performance Funding: $3,750,000

This amount is subject to the availability of funds.

Estimated Total Funding: $3,750,000

6. Approximate Period of Performance Length: 3 year(s)

7. Expected Number of Awards: 4

8. Approximate Average Award: $312,500 Per Budget Period

9. Award Ceiling: $0 Per Budget Period

This amount is subject to the availability of funds.

10. Award Floor: $0 Per Budget Period

11. Estimated Award Date: 08/30/2020

12. Budget Period Length: 12 month(s)

Throughout the project period, CDC will continue the award based on the availability of funds, the evidence of satisfactory progress by the recipient (as documented in required reports), and the determination that continued funding is in the best interest of the federal government. The total number of years for which federal support has been approved (project period) will be shown in the “Notice of Award.” This information does not constitute a commitment by the federal government to fund the entire period. The total period of performance comprises the initial competitive segment and any subsequent non-competitive continuation award(s).

13. Direct Assistance Direct Assistance (DA) is not available through this NOFO.

C. Eligibility Information

1. Eligible Applicants Eligibility Category: State governments

County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification) Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

Additional Eligibility Category:

Government Organizations:

State governments or their bona fide agents (includes the District of Columbia)

Local governments or their bona fide agents

Territorial governments or their bona fide agents in the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.

State controlled institutions of higher education

American Indian or Alaska Native tribal governments (federally recognized or state-recognized)

Non-government Organizations:

American Indian or Alaska native tribally designated organizations

Other:

Ministries of Health

2. Additional Information on Eligibility Privates colleges and universities, Community-based organizations, Faith-based organizations, For-profit organizations (other than small business), Small businesses

N/A

3. Justification for Less than Maximum Competition N/A

4. Cost Sharing or Matching Cost Sharing / Matching Requirement: No

5. Maintenance of Effort

D. Application and Submission Information

1. Required Registrations An organization must be registered at the three following locations before it can submit an application for funding at www.grants.gov.

a. Data Universal Numbering System:

All applicant organizations must obtain a Data Universal Numbering System (DUNS) number.

A DUNS number is a unique nine-digit identification number provided by Dun & Bradstreet (D&B). It will be used as the Universal Identifier when applying for federal awards or cooperative agreements.

The applicant organization may request a DUNS number by telephone at 1-866-705-5711 (toll free) or internet at http:// fedgov.dnb. com/ webform/ displayHomePage.do. The DUNS number will be provided at no charge.

If funds are awarded to an applicant organization that includes sub-recipients, those sub-recipients must provide their DUNS numbers before accepting any funds.

b. System for Award Management (SAM):

The SAM is the primary registrant database for the federal government and the repository into which an entity must submit information required to conduct business as a recipient. All https://www.grants.gov/ http://fedgov.dnb.com/webform/displayHomePage.do applicant organizations must register with SAM, and will be assigned a SAM number. All information relevant to the SAM number must be current at all times during which the applicant has an application under consideration for funding by CDC. If an award is made, the SAM information must be maintained until a final financial report is submitted or the final payment is received, whichever is later. The SAM registration process can require 10 or more business days, and registration must be renewed annually. Additional information about registration procedures may be found at https://www.sam.gov/SAM/.

c. Grants.gov:

The first step in submitting an application online is registering your organization at www.grants.gov, the official HHS E-grant Web site. Registration information is located at the "Applicant Registration" option at www.grants.gov.

All applicant organizations must register at www.grants.gov. The one-time registration process usually takes not more than five days to complete. Applicants should start the registration process as early as possible.

Step System Requirements Duration Follow Up 1 Data

Universal Number System

(DUNS)

1. Click on http:// fedgov.dnb.com/ webform

2. Select Begin DUNS search/request process

3. Select your country or territory and follow the instructions to obtain your DUNS 9-digit #

4. Request appropriate staff member(s) to obtain DUNS number, verify & update information under DUNS number

1-2 Business Days

To confirm that you have been issued a new DUNS number check online at (http:// fedgov.dnb.com/ webform) or call 1-866-705-5711

2 System for Award Management

(SAM)

formerly Central Contractor Registration

(CCR)

1. Retrieve organizations DUNS number

2. Go to https://www.sam.gov/SAM/ and designate an E-Biz POC (note CCR username will not work in SAM and you will need to have an active SAM account before you can register on grants.gov)

3-5 Business Days but up to 2 weeks and must be renewed once a year

For SAM Customer Service Contact https://fsd.gov/ fsd-gov/ home.do Calls:

866-606-8220

3 Grants.gov 1. Set up an individual account in Grants.gov using organization new DUNS number to become an

Same day but can take 8 weeks to be

Register early!

Log into grants.gov and check AOR https://www.sam.gov/SAM/ https://grants.gov/ https://www.grants.gov/ http://www.grants.gov https://www.grants.gov/ http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform http://fedgov.dnb.com/webform https://www.sam.gov/SAM/ https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do https://fsd.gov/fsd-gov/home.do authorized organization representative (AOR)

2. Once the account is set up the E-BIZ POC will be notified via email

3. Log into grants.gov using the password the E-BIZ POC received and create new password

4. This authorizes the AOR to submit applications on behalf of the organization fully registered and approved in the system (note, applicants

MUST

obtain a

DUNS

number and

SAM

account before applying on grants.gov) status until it shows you have been approved

2. Request Application Package Applicants may access the application package at www.grants.gov.

3. Application Package Applicants must download the SF-424, Application for Federal Assistance, package associated with this notice of funding opportunity at www.grants.gov.

4. Submission Dates and Times If the application is not submitted by the deadline published in the NOFO, it will not be processed. Office of Grants Services (OGS) personnel will notify the applicant that their application did not meet the deadline. The applicant must receive pre-approval to submit a paper application (see Other Submission Requirements section for additional details). If the applicant is authorized to submit a paper application, it must be received by the deadline provided by

OGS.

a. Letter of Intent Deadline (must be emailed or postmarked by) Due Date for Letter of Intent: 04/13/2020

b. Application Deadline Due Date for Applications: 05/11/2020 , 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. If Grants.gov is inoperable and cannot receive applications, and circumstances preclude advance notification of an extension, then applications must be submitted by the first business day on which grants.gov operations resume.

Date for Information Conference Call Informational conference call for potential applicants Monday, March 23, 2020 1:00-2:30pm

EST

https://www.grants.gov https://www.grants.gov

Join Skype Meeting Trouble Joining? Try Skype Web App Join by phone

(404) 553-8912 (Atlanta Dial-in Conference Region) English (United States)

(855) 348-8390 (Atlanta Dial-in Conference Region) English (United States) Find a local number Conference ID: 9285150

5. CDC Assurances and Certifications All applicants are required to sign and submit “Assurances and Certifications” documents indicated at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa)) /Homepage.aspx.

Applicants may follow either of the following processes:

Complete the applicable assurances and certifications with each application submission, name the file “Assurances and Certifications” and upload it as a PDF file with at www.grants.gov

Complete the applicable assurances and certifications and submit them directly to CDC on an annual basis at http://wwwn.cdc.gov/ grantassurances/ (S(mj444mxct51lnrv1hljjjmaa))/ Homepage.aspx

Assurances and certifications submitted directly to CDC will be kept on file for one year and will apply to all applications submitted to CDC by the applicant within one year of the submission date.

Risk Assessment Questionnaire Requirement CDC is required to conduct pre-award risk assessments to determine the risk an applicant poses to meeting federal programmatic and administrative requirements by taking into account issues such as financial instability, insufficient management systems, non-compliance with award conditions, the charging of unallowable costs, and inexperience. The risk assessment will include an evaluation of the applicant’s CDC Risk Questionnaire, located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, as well as a review of the applicant’s history in all available systems; including OMB-designated repositories of government-wide eligibility and financial integrity systems (see 45 CFR 75.205(a)), and other sources of historical information. These systems include, but are not limited to: FAPIIS (https://www.fapiis.gov/), including past performance on federal contracts as per Duncan Hunter National Defense Authorization Act of 2009; Do Not Pay list; and System for Award Management (SAM) exclusions.

CDC requires all applicants to complete the Risk Questionnaire, OMB Control Number 0920- 1132 annually. This questionnaire, which is located at https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf, along with supporting documentation must be submitted with your application by the closing date of the https://webconf.cdc.gov/nhh9/4M92RZHC https://webconf.cdc.gov/nhh9/4M92RZHC?sl=1 tel:(404)%20553-8912 tel:(855)%20348-8390 https://webaudio.cdc.gov/ http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx https://www.grants.gov http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx http://wwwn.cdc.gov/grantassurances/(S(mj444mxct51lnrv1hljjjmaa))/Homepage.aspx https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf https://www.cdc.gov/grants/documents/PPMR-G-CDC-Risk-Questionnaire.pdf

Notice of Funding Opportunity Announcement. If your organization has completed CDC’s Risk Questionnaire within the past 12 months of the closing date of this NOFO, then you must submit a copy of that questionnaire, or submit a letter signed by the authorized organization representative to include the original submission date, organization’s EIN and DUNS.

When uploading supporting documentation for the Risk Questionnaire into this application package, clearly label the documents for easy identification of the type of documentation. For example, a copy of Procurement policy submitted in response to the questionnaire may be labeled using the following format: Risk Questionnaire Supporting Documents _ Procurement Policy.

Duplication…